1. Home
  2. NKTR vs EYE Comparison

NKTR vs EYE Comparison

Compare NKTR & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$71.90

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$19.25

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
EYE
Founded
1990
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
NKTR
EYE
Price
$71.90
$19.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
$146.67
$31.22
AVG Volume (30 Days)
1.2M
2.3M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
202.78
EPS
N/A
0.38
Revenue
$307,711,000.00
$1,987,488,000.00
Revenue This Year
N/A
$5.56
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
$51.08
Revenue Growth
86.00
9.00
52 Week Low
$21.02
$14.75
52 Week High
$109.00
$30.02

Technical Indicators

Market Signals
Indicator
NKTR
EYE
Relative Strength Index (RSI) 59.67 56.15
Support Level $64.30 $14.84
Resistance Level $76.67 $29.56
Average True Range (ATR) 4.21 0.82
MACD 1.55 0.28
Stochastic Oscillator 77.06 70.63

Price Performance

Historical Comparison
NKTR
EYE

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

Share on Social Networks: